NOT KNOWN DETAILS ABOUT HEMGENIX

Range of suitable people: CDEC discussed the uncertainty in the number of patients with moderately severe to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some patients who will be categorised as owning delicate or reasonable condition could have a extreme bleeding phenotyp